How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

EN

NASDAQ:ENVB
Get a brief AI stock analysisSaves ~ 15 minutes of your time

EN

Enveric Biosciences IncNASDAQ ENVB Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is ENVB undervalued compared to its fair value?

The fair value of ENVB stock is hidden USD. Relative to the market price of 0.47 USD Enveric Biosciences Inc is hidden.

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. The company is headquartered in Naples Florida, Florida and currently employs 23 full-time employees. The company went IPO on 2009-07-21...[More about valuation]

Enveric Biosciences Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.004 $B

Price:

0.47 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-1.306

FINANCIALS

Enveric Biosciences financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0035 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0028 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.0066 B
0.0024 B

Financial Position Analysis

Assets

0.0066 B
Current Assets
0.0058 B
Total non-current assets
0.0008 B

Total current liabilities
0.0042 B
Total non-current liabilities

Cash Flow Statement

-0.0027 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0027 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Enveric Biosciences fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is ENVB attractive for investment based on fundamental analysis?

ENVB stock rating is hidden. Enveric Biosciences is a hidden by Eyestock methodology.

Get ENVB Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

ENVB analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for ENVB to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Enveric Biosciences Inc competitors

LL

LLY

Eli Lilly and Co

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs ...

Discover

NO

NOVO B.CO

Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged i...

Discover

JN

JNJ

Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in Ne...

Discover

Enveric Biosciences Inc dividends

ENVB dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About ENVB stock

About the company Enveric Biosciences Inc

Market cap $B

0.004

Dividend yield

Shares outstanding

2.07827 B

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. The company is headquartered in Naples Florida, Florida and currently employs 23 full-time employees. The company went IPO on 2009-07-21. The firm is developing next-generation mental health and oncology treatments using a clinical discovery platform to enable psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. The company is developing its product candidates that are focused on cannabinoids derived from non-hemp botanical sources, and synthetic materials containing no tetrahydrocannabinol (THC) in order to comply with United States federal regulations. Its product candidates include EV104, EVM-101, EVM-201, EVM-301, EV102 and EV101. EV104 includes cannabidiol (CBD) and celecoxib conjugate. EVM-101 is a first-generation psychedelic asset, which is a psilocybin oral formulation. EVM-201 is a second-generation psychedelic asset, which is a prodrug of psilocin. EVM-301 is a third-generation psychedelic. EV102 is a cannabinoid cream for topical skin application. EV101 is a cannabinoid plus chemotherapy combination therapy.

ENVB profile

  • Ticker

    ENVB

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    21 July 2009

  • Sector

    Healthсare

  • Industry

    Pharmaceuticals

  • Employees

    23

  • City

    Naples Florida

  • Address

    4851 Tamiami Trail N, Suite 200

  • Cusip

    29405E208